Grzeszczak, W., Szczyra, D., & Śnit, M. (2021). Whether Prolyl Hydroxylase Blocker—Roxadustat—In the Treatment of Anemia in Patients with Chronic Kidney Disease Is the Future? Int J Environ Res Public Health.
शिकागो स्टाइल उद्धरणGrzeszczak, Władysław, Dariusz Szczyra, और Mirosław Śnit. "Whether Prolyl Hydroxylase Blocker—Roxadustat—In the Treatment of Anemia in Patients With Chronic Kidney Disease Is the Future?" Int J Environ Res Public Health 2021.
एमएलए उद्धरणGrzeszczak, Władysław, Dariusz Szczyra, और Mirosław Śnit. "Whether Prolyl Hydroxylase Blocker—Roxadustat—In the Treatment of Anemia in Patients With Chronic Kidney Disease Is the Future?" Int J Environ Res Public Health 2021.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.